Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

3 recruiting1 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT07531927Not ApplicableRecruiting

Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy

Role: lead

NCT07548944Recruiting

Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance

Role: lead

NCT06682962Not ApplicableRecruiting

Transcorneal Electrical Stimulation for the Treatment of Visual Field Defects in Patients With Open-Angle Glaucoma

Role: lead

NCT04983914Completed

Retrospective NIS to Evaluate the Patient Benefit of TES

Role: lead

NCT01837901Not ApplicableCompleted

Transcorneal Electrostimulation for Therapy of Retinitis Pigmentosa

Role: lead

NCT01835002Not ApplicableCompleted

Transcorneal Electrical Stimulation - Multicenter Safety Study

Role: lead

NCT02548572Not ApplicableWithdrawn

Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Safety and Efficacy Multicenter Study

Role: collaborator

NCT00804102Not ApplicableCompleted

Transcorneal Electrical Stimulation Therapy for Retinal Disease

Role: lead

All 8 trials loaded